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Hispanic men have higher rates of illness and death from various
chronic conditions than do non-Hispanic men. We aimed to char-
acterize  the  health  of  Mexican  American  men  living  on  the
US–Mexico border in South Texas and elucidate indications of
chronic disease in young men.
Methods
We sampled all male participants from the Cameron County His-
panic Cohort,  an ongoing population-based cohort of Mexican
Americans in Brownsville, Texas. We calculated descriptive stat-
istics and stratified the sample into 3 age groups to estimate the
prevalence of sociodemographic, behavioral, and clinical factors
by age group and evaluated differences between age groups.
Results
Obesity prevalence was approximately 50% across all age groups
(P = .83).  Diabetes  prevalence was high overall  (26.8%),  and
16.9% (95% confidence  interval  [CI],  10.1%–23.8%)  of  men
younger than 35 had diabetes. More than 70% of these young men
had elevated liver enzymes, and mean values of aspartate amino-
transferase were significantly higher in younger men (45.0 u/L;
95% CI, 39.5–50.6 u/L) than in both older age groups. Less than
20% of young men had any form of health insurance.  Current
smoking was higher in young men than in men in the other groups,
and the rate was higher than the national prevalence of current
smoking among Hispanic men.
Conclusions
We suggest a need for obesity and diabetes prevention programs
and smoking cessation programs for men in this region. Opportun-
ities exist to expand current intervention programs and tailor them
to better reach this vulnerable population of young Hispanic men.
Elevated liver enzymes in men younger than 35 suggest a substan-
tial burden of liver abnormalities, a finding that warrants further
study.
Introduction
Hispanic men comprise a rapidly growing demographic of the
United States, yet the research literature on Hispanic men’s health
is sparse. Studies indicate that Hispanics in the United States face
many health inequities,  ranging from lack of access to care to
higher rates of infectious and chronic diseases (1–4). However,
few studies have addressed health inequalities in Hispanic men
(3,4). Despite having a longer life expectancy than non-Hispanic
white men (5), Hispanic men have higher mortality rates than do
non-Hispanic men for chronic conditions such as type 2 diabetes,
end-stage renal disease, colorectal cancer (6), and liver disease (7).
Research suggests that a lack of access to care contributes to this
increased risk of death from chronic conditions in Hispanic men
(8).
Hispanic men are an epidemiologically heterogeneous group. Im-
provements in Hispanic health surveillance data (9) and data from
the Hispanic Community Health Study/Study of Latinos (HCHS/
SOL) and others indicate disparate health outcomes in Hispanics
by ethno-regional subgroup (3,10,11). However, to date, studies
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that  examined  the  health  of  Hispanic  ethnic  subgroups  in  the
United States neglect men’s health; of the 37 publications that
emerged from the HCHS/SOL, none specifically studied men’s
health (12). As an additional illustration of the dearth of health re-
search in US Hispanic men, a 2016 MeSH term search of “men’s
health” and “Hispanic Americans or Mexican Americans” on Ovid
Medline yielded only 20 relevant articles since 1946.
This study describes the health characteristics of Mexican Ameri-
can men on the southern Texas–Mexico border in Brownsville,
Texas. This area is resource-poor, among the poorest cities in the
United States (13). With a population of primarily Mexican des-
cent (93.2% Hispanic, of whom 86.2% are of Mexican descent),
data from this ethnically homogenous population of men are ideal
for  comparing  with  those  of  nationwide  surveys  of  Mexican
American men’s health (such as the National Health and Nutrition
Examination Survey and HCHS/SOL). We have shown that this
population has high rates of obesity, insulin resistance, diabetes,
liver disease, and subclinical atherosclerosis, with significant dif-
ferences by sex (14–19). Additionally, in reviewing the data from
the  Cameron County  Hispanic  Cohort  (CCHC),  a  population-
based cohort study of the region, we observed high rates of obesity
in younger men (younger than 35 years). The purpose of this study
is to further characterize men’s health by age group to assess the
burden of chronic disease in younger men. Age is a relevant trait
for risk stratification and intervention, and a precise characteriza-
tion of the population is fundamental to any further work in Mex-
ican American men.
Methods
We conducted a cross-sectional analysis of 945 men in the CCHC
from Brownsville, Texas, recruited from 2004 through 2015. The
CCHC is a representative sample of the Mexican American popu-
lation in South Texas, selected by a 2-stage methodology using US
Census data; socioeconomic quartiles are the sampling strata, and
census blocks are the randomized sampling units. We invited all
members (aged 18 years or older) of all households in the selected
blocks to participate in the CCHC. Participants gave informed
consent and then came to the local clinical research unit where ex-
tensive sociodemographic, clinical, and laboratory data were col-
lected.  We  have  detailed  these  protocols  previously  (14,15).
Trained bilingual health workers conducted a clinical exam and
health interview in the participants’ language of preference (Eng-
lish or Spanish). Participants arrived fasting for 10 hours so that
blood samples could be obtained for a comprehensive metabolic
panel, complete blood count with differential,  and hemoglobin
A1c (HbA1c) measurements. The study team measured anthropo-
metrics  and  blood  pressure  and  asked  participants  a  range  of
demographic, clinical, health care use, and health behavior ques-
tions.
Definitions
The definition of elevated liver function tests (LFTs) was alanine
transaminase (ALT) levels greater than 40 u/L and/or aspartate
aminotransferase (AST) levels greater than 37 u/L. We used the
2010 American Diabetes Association diagnostic criteria for dia-
betes mellitus (DM) (20). A body mass index (BMI) of more than
30 kg/m2  indicated obesity.  We defined hypertension as mean
systolic blood pressure (SBP) at or above 130 mm Hg or a mean
diastolic blood pressure (DPB) at or above 85 mm Hg, or taking
antihypertensive medication. Three or more of the following con-
stituted metabolic syndrome: hypertension, triglyceride levels over
150 mg/dL, high-density lipoprotein (HDL) cholesterol levels less
than 40 mg/dL, fasting blood glucose over 100 mg/dL or taking
hypoglycemic medication, or waist circumference higher than 102
cm (21). Total cholesterol of more than 200 mg/dL indicated hy-
percholesterolemia. A “heavy drinker” was any participant report-
ing drinking more than 14 alcoholic drinks per week (22). We
defined history of smoking as an affirmative response to the ques-
tion, “Have you ever smoked more than 100 cigarettes in your en-
tire life?” and current smoking as an affirmative response to the
question, “Do you now smoke cigarettes?” among those with a
history of smoking.
Statistical methods
The CCHC has a 2-stage population-based sampling methodology.
To address possible sampling bias, we adjusted all analyses for the
probability  of  sampling using age-  and sex-adjusted sampling
weights, based on the population of Brownsville, Texas. We also
accounted for the potential clustering effect among participants
from the same household or census block. We considered results
statistically significant at P < .05. In descriptive analyses, we cal-
culated unweighted frequencies and weighted proportions for cat-
egorical variables. We then stratified participants into 3 age groups
(younger, aged 18–34 years; middle-aged, 35–54 years; and older,
aged  ≥55  years)  to  estimate  health  outcomes  by  age  group.
Weighted proportions of participants in each age group were ap-
proximately equal (Rao-Scott χ2 = 1.3, P = .53).
We used the Rao-Scott χ2 test to assess equality of proportions of
categorical variables across age groups. For continuous variables,
we used survey-weighted linear regression analysis to detect dif-
ferences in mean values across age groups. For blood pressure
analysis, we adjusted for current antihypertensive medication, and
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for analyses of triglycerides and LDL and HDL cholesterol vari-
ables, we adjusted for lipid-controlling medications. Because this
population is binational,  we sought to rule out confounding of
place of birth on the results; using logistic and linear regression,
we repeated each analysis controlling for place of birth. Where the
adjustment for place of birth affected results, we have noted this
effect; otherwise, crude results are presented.
In the case of a significant independent overall association of age
with the variable of interest, we used multiple comparisons tech-
niques to detect significant differences in the younger age group
compared with the other age groups. For categorical associations,
we used logistic regression to calculate odds ratios (ORs) for the
outcome of interest in the younger age group compared with the
other age groups.  For significant associations with continuous
variables, we applied regression models to obtain t-test results
with Bonferroni-adjusted P values for multiple pairwise comparis-
ons across age groups; we reported the difference of least square
means and associated 95% confidence intervals (CIs) and P val-
ues. For all  analyses, we used SAS version 9.4 (SAS Institute,
Inc).
Results
Characteristics of the study population
We excluded 86 participants who were missing critical data; our
final sample was 945 men from the CCHC. Mean age of parti-
cipants was 44.3 years, and approximately half (50.4%) were born
in Mexico (Table 1). The mean age of men born in the United
States (40.4 y) was significantly lower than the mean age of men
born outside the United States (48.0 y, P = .002; data not shown).
Confounding by place of birth was significant for only one analys-
is:  multiple comparisons of AST levels.  The remaining results
were not significantly affected when adjusting for place of birth,
so crude results are presented. Most participants (63.6%) had no
medical insurance (including Medicare and Medicaid), and 18.9%
were unemployed (not retired) at the time of the interview. Many
participants (38.5%) declined to provide income data. Approxim-
ately half of the participants had a history of smoking (54.2%),
and 28.4% were current smokers. With regard to drinking habits,
7.3% reported heavy drinking, and 60.3% reported occasional al-
cohol consumption. We found high rates of metabolic abnormalit-
ies: 49.9% of participants were obese, 26.8% had diabetes, 44.0%
met the criteria for metabolic syndrome, and 64.4% had elevated
liver enzymes (Table 1).
Stratified and multiple comparisons analyses
Obesity prevalence was similar across age groups, at approxim-
ately 50% (P = .83) (Table 2). Mean waist circumference (P = .29)
and mean BMI (P = .19) were also similar across age groups. The
proportion with diabetes was significantly associated with age
group (P < .001). This proportion was highest in the older age
group (38.2%; 95% CI, 29.3%–47.1%), although 16.9% (95% CI,
10.1%–23.8%) of the younger age group had diabetes. Addition-
ally, 51.3% (95% CI, 42.9%–59.8%) of men in the younger group
had either prediabetes or diabetes, and this prevalence was even
higher in the other 2 age groups (Figure 1).
Figure 1. Proportion of male participants with diabetes, prediabetes,
and prediabetes or diabetes, by age group, Cameron County Hispanic
Cohort,  2004–2015.  This  figure  shows  that  prevalence  of
prediabetes is above 30% across age groups and that more than
50% of men younger than 35 years in this population have either
diabetes or prediabetes.
 
The proportion of men with elevated LFTs was significantly asso-
ciated with age group (P = .001). In multiple comparisons analys-
is, the odds of elevated LFTs was significantly lower in the older
age group than in  the  younger  age group (OR = 0.4;  95% CI,
0.3–0.8). When examining continuous values of ALT and AST,
we found differences in both mean ALT (P < .001) and mean AST
(P = .002) across age groups (Figure 2). In multiple comparisons
(Table 3), both ALT and AST mean levels were significantly high-
er in the younger group than in the older group (ALT difference:
17.2 u/L; 95% CI, 7.4–27.0; P < .001; AST difference: 11.2 u/L;
95% CI, 3.7–18.7; P = .001). AST mean levels were also signific-
antly higher in the younger group than in the middle-aged group
(difference: 7.1 u/L; 95% CI, 0.02–14.1; P = .05), but this finding
did not  remain significant  when controlling for  place of  birth.
There was an overall association between elevated triglycerides
and age group (P = .01). Multiple comparisons indicated that the
odds  of  elevated  triglycerides  was  significantly  higher  in  the
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middle-aged group than in the younger group (OR = 2.2; 95% CI,
1.4–3.4), as were mean levels of triglycerides (difference: −48.4
mg/dL, 95% CI, −87.1 to −9.7, P = .008). We observed that the
younger age group had a 37.5% prevalence of elevated trigly-
ceride levels  (95% CI,  29.1%–45.9%) (Table 2).  Furthermore,
33.7% of men aged 18 to 34 years (95% CI, 25.2%–42.1%) satis-
fied the criteria for metabolic syndrome, compared with 57.3% of
men aged 55 years or older (95% CI, 47.4%–67.3%), with a signi-
ficant overall association with age group (P < .001).
Figure 2. Mean levels of ALT and AST, by age group, male participants
of the Cameron County Hispanic Cohort, 2004–2015. Mean levels of
ALT and AST are highest in men younger than 35 and lower in older
age groups.  The upper limit  of  normal for  ALT is  40 u/L,  and the
upper limit of normal for AST is 37 u/L (indicated by horizontal lines
on graph). Abbreviations: ALT, alanine transaminase; AST, aspartate
aminotransferase.
 
The proportion of men with health insurance was highest in the
older age group (61.8%; 95% CI, 53.0%–70.6%), and lowest in
the younger age group (19.2%; 95% CI, 11.7%–26.8%), with an
overall significant association (P < .001) between age group and
insurance (Table 2). Having health insurance was also signific-
antly associated with being born in the United States (OR = 2.1;
95% CI, 1.4–3.2; data not shown), but both age group and place of
birth remained independently associated with insurance status in
logistic regression (data not shown).
Rates of current smoking were highest in the younger age group
(35.4%; 95% CI, 27.2%–43.6%) and lowest in the older age group
(19.4%; 95% CI, 12.9%–25.8%), with an overall significant asso-
ciation with age (P = .006). Multiple comparisons indicated that
current smoking prevalence was significantly higher in the young-
er group than in the older group (OR [older vs younger] = 0.4;
95% CI, 0.2–0.7) but similar to the middle group. Overall history
of smoking (past or present) and drinking behavior had no signi-
ficant associations with age group.
Discussion
This  article  is  among the  few population-based studies  of  the
health of  Mexican American men,  and it  allows for  evidence-
based risk stratification by age in the Mexican American popula-
tion. Before this study, little was known about the health needs of
Mexican American men in the southern Texas–Mexico border re-
gion. Our results show strikingly adverse metabolic and behavior-
al outcomes in men younger than 35 years. Poor metabolic health
(eg, dyslipidemia, elevated blood pressure, obesity, and predia-
betes) appears to extend into the 35 to 54 years age group. Vari-
ables that tend to be associated with older age — such as hyper-
tension, diabetes, and metabolic syndrome — were also associ-
ated with older age in this population. Mean BMI and mean waist
circumference were uniform but high across all age groups. Al-
though mounting evidence suggests that metabolic health, as op-
posed to obesity, is a more important indicator of cardiovascular
risk (16,23,24), obesity is an important predictor of several health
outcomes. In this population, obesity begins in adolescence (25)
and persists through middle and older age.
A relevant finding from this study was the significant burden of
obesity, prediabetes, and diabetes in the younger age group. Out-
comes such as obesity tend to peak during middle age in men (26),
but we found a 48.9% prevalence of obesity in younger men. For
comparison, the HCHS/SOL study found a 36.8% prevalence of
obesity in 2,337 Mexican American men in their nationwide sur-
vey (10); our findings suggest a higher burden of obesity in Mex-
ican American men residing on the Texas–Mexico border than in
Mexican American men nationwide. We found a 34.3% preval-
ence  of  prediabetes  and  16.9%  prevalence  of  diabetes  in  the
younger group. Although high rates of diabetes have been docu-
mented in this population (15,27), our findings indicate a high pre-
valence of diabetes in young men, which has not been widely ad-
dressed in the literature. Nationwide, the overall prevalence of dia-
betes among Mexican American men is 18.7% (28), so the preval-
ence of  diabetes  in  men younger  than 35 in this  population is
nearly as high as the nationwide average for all ages. Employing
widely  used  cut-offs  for  elevated  ALT and  AST,  we  found  a
70.2% prevalence of elevated LFTs in the younger group, which
was similar to the prevalence for the middle-aged group and signi-
ficantly higher than that for the older group. Research indicates
that ALT levels may decrease slightly with age (29), but our find-
ings were nonetheless remarkable. Given the documented high
rates of nonalcoholic fatty liver disease in this cohort (30), the au-
thors believe that this association is real and that the drivers of el-
evated liver enzymes in young Mexican American men warrant
further study.
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The younger group fares worse than the older groups in 2 other
important measures: lack of health insurance and high rates of cur-
rent smoking. We found that less than 20% of men younger than
35 had any health care coverage. Limited resources exist for unin-
sured, and especially undocumented, men to obtain affordable
health care, so preventive care may not be sought by this young
population. Among men in the younger age group, 51.5% had a
history of smoking and 35.4% identified as current smokers. The
percentage of young men with any history of smoking was higher
(though not significantly) than the percentage of older men with a
history of smoking (51.5% vs 40.0%). This finding suggests that
smoking initiation across generations is consistent. Both the rate
of current smoking among younger men in the CCHC (35.4%) and
rate of current smoking among all men in the CCHC (28.4%) ap-
pear to be higher than the overall rate of current smoking in US
Hispanic men (17.3%) (31).
Although poor health outcomes were not restricted to the younger
group, the findings in this group provoke the greatest  concern
from a prevention perspective. The high prevalence of poor meta-
bolic health outcomes in Mexican Americans is now well docu-
mented (14,17,26),  but  the high prevalence of  poor  metabolic
health outcomes in young men has not yet been adequately stud-
ied. Given that more than 60% of the overall male population in
this region lacks health insurance and that men in general are less
likely to exhibit health-seeking behavior than women (4), these
data support the need for aggressive chronic disease intervention
programs for young Mexican American men.
There were several limitations to this study. The data we used
were cross-sectional and do not provide insight into changes in
health over time or causality. Only longitudinal data will allow us
to determine whether the differences in the age groups are cohort
effects or whether we may see premature death in metabolically
unhealthy young men, or both. Additionally, many participants de-
clined to provide income information. Despite these limitations,
we contribute to the characterization of Mexican American men’s
health, affirming the importance of stratified analyses of health
among Hispanic  men of  distinct  ages  and ethno-regional  sub-
groups.
There  are  active  obesity  and  diabetes  prevention  programs in
South Texas, but we suspect that men are missed by these efforts.
For  example,  the  Coordinated  Approach  to  Child  Health
(CATCH) targets obesity in children and families, and “Salud y
Vida”  aims  to  prevent  diabetes  in  people  with  prediabetes.
However, less than 30% of participants in “Salud y Vida” are men
(M. Zolezzi, University of Texas School of Public Health, written
communication, 2015). Men rarely attend free exercise classes
offered by the University of Texas School of Public Health (A.
Davé, University of Texas School of Public Health, written com-
munication, 2016). The literature corroborates these findings, sug-
gesting that interventions should be consciously tailored toward
men  (32).  Additionally,  we  suspect  that  vastly  different  ap-
proaches are needed for each age group. We believe our findings
will contribute to a re-evaluation of intervention programs in the
region and shape new interventions targeting men at highest risk.
Our data also suggest that men in South Texas would benefit from
culturally  appropriate  smoking  cessation  programs.  Lower
smoking rates would consequently reduce overall cardiovascular
risk. By prioritizing younger men for primary prevention, we can
reduce poor health behaviors (eg, poor diet, sedentary lifestyle, to-
bacco use) that begin in early adulthood or even before and mitig-
ate the burden of more severe disease (eg, cardiovascular disease,
diabetes, cancer) later in life.
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Tables
Table 1. Descriptive Statistics of Men in the Cameron County Hispanic Cohort (N = 945), 2004–2015
Participant Characteristic Valuea
Mean age, y (SE) (n = 945) 44.3 (1.0)
Mean years in Brownsville (SE) (n = 945) 28.2 (1.9)
Mean weight, kg (SE) (n = 945) 90.3 (1.0)
Mean height, cm (SE) (n = 945) 170.7 (0.3)
Mean waist circumference, cm (SE) (n = 945) 105.2 (0.7)
Mean waist-to-hip ratio (SE) (n = 945) 1.0 (0)
Mean body mass index, kg/m2 (SE) (n = 945) 30.9 (0.3)





Insuranceb (n = 944)
No insurance 63.6
Insurance 36.3





Not in workforce 4.4




Education level (n = 945)
Completed high school 58.3
Abbreviation: SE, standard error.
a All statistics weighted. Percentages may not reflect the expected value due to sampling weights and design-based analyses. Values expressed
as percentages, unless otherwise indicated.
b “Insurance” includes both public and private coverage of any type.
c Defined as an affirmative response to, “Have you ever smoked more than 100 cigarettes in your entire life?”
d Defined as affirmative responses to 1) “Have you ever smoked more than 100 cigarettes in your entire life?” and 2) “Do you now smoke cigar-
ettes?”
e Defined as alanine transaminase >40 u/L and/or aspartate aminotransferase >37 u/L.
f According to American Diabetes Association 2010 Diagnostic Guidelines (20).
g Calculated low-density lipoprotein cholesterol levels.
h Defined as systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or currently taking antihypertensive medication.
i According to Adult Treatment Panel III (21).
(continued on next page)
PREVENTING CHRONIC DISEASE VOLUME 13, E113
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY       AUGUST 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
8       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2016/16_0020.htm
(continued)
Table 1. Descriptive Statistics of Men in the Cameron County Hispanic Cohort (N = 945), 2004–2015
Participant Characteristic Valuea
Did not complete high school 41.7
History of smokingc (n = 945)
Yes 54.2
No 45.8
Current smokerd (n = 945)
Yes 28.4
No 71.6
Drinking (n = 944)
Never 39.7
Sometimes 60.3
Heavy drinking (drinks/wk) (n = 945)
Yes (>14) 7.3
No (≤14) 92.7
Elevated liver enzymese (n = 945)
No 35.6
Yes 64.4
Body mass index categories (kg/m2) (n = 945)
Not obese (≤ 30) 50.1
Obese (>30) 49.9




Hypertriglyceridemia (mg/dL) (n = 945)
No (≤150) 52.5
Yes (>150) 47.5
High-density lipoprotein cholesterol (mg/dL) (n = 945)
Abbreviation: SE, standard error.
a All statistics weighted. Percentages may not reflect the expected value due to sampling weights and design-based analyses. Values expressed
as percentages, unless otherwise indicated.
b “Insurance” includes both public and private coverage of any type.
c Defined as an affirmative response to, “Have you ever smoked more than 100 cigarettes in your entire life?”
d Defined as affirmative responses to 1) “Have you ever smoked more than 100 cigarettes in your entire life?” and 2) “Do you now smoke cigar-
ettes?”
e Defined as alanine transaminase >40 u/L and/or aspartate aminotransferase >37 u/L.
f According to American Diabetes Association 2010 Diagnostic Guidelines (20).
g Calculated low-density lipoprotein cholesterol levels.
h Defined as systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or currently taking antihypertensive medication.
i According to Adult Treatment Panel III (21).
(continued on next page)
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(continued)




Low-density lipoprotein cholesterolg (mg/dL) (n = 945)
Normal (≤160) 92.7
Elevated (>160) 7.3
Hypertensionh (n = 945)
No 66.1
Yes 33.9
Metabolic syndromei (n = 945)
No 56.0
Yes 44.0
Abbreviation: SE, standard error.
a All statistics weighted. Percentages may not reflect the expected value due to sampling weights and design-based analyses. Values expressed
as percentages, unless otherwise indicated.
b “Insurance” includes both public and private coverage of any type.
c Defined as an affirmative response to, “Have you ever smoked more than 100 cigarettes in your entire life?”
d Defined as affirmative responses to 1) “Have you ever smoked more than 100 cigarettes in your entire life?” and 2) “Do you now smoke cigar-
ettes?”
e Defined as alanine transaminase >40 u/L and/or aspartate aminotransferase >37 u/L.
f According to American Diabetes Association 2010 Diagnostic Guidelines (20).
g Calculated low-density lipoprotein cholesterol levels.
h Defined as systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or currently taking antihypertensive medication.
i According to Adult Treatment Panel III (21).
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n % (95% CI) n % (95% CI) n % (95% CI)
Obese BMI (>30 kg/m2) (n = 945) 129 48.9 (40.4–57.4) 207 52.4 (45.9–58.9) 114 50.2 (40.3–60.1) .83
Diabetesb (n = 933) 39 16.9 (10.1–23.8) 106 26.3 (20.8–31.8) 116 38.2 (29.3–47.1) <.001
Prediabetes or diabetesb (n = 933) 125 51.3 (42.9–59.8) 243 60.6 (54.0–67.3) 215 82.2 (75.9–88.6) <.001
Elevated LFTsc (n = 945) 218 70.2 (62.0–78.5) 282 70.4 (64.3–76.6) 127 51.2 (41.4–61.0) .001
Reduced HDLd (n = 945) 108 41.2 (32.7–49.7) 149 35.9 (29.8–41.9) 107 44.0 (34.1–53.8) .37
Elevated LDLe (n = 933) 17 5.2 (2.3–8.2) 40 9.7 (6.3–13.1) 20 7.0 (3.2–10.8) .19
Hypertriglyceridemiaf (n = 945) 104 37.5 (29.1–45.9) 226 56.9 (50.4–63.4) 137 48.1 (38.2–58.0) .005
Hypertensiong (n = 945) 49 23.8 (15.3–32.3) 97 24.2 (18.8–29.6) 144 56.0 (46.5–65.6) <.001
Metabolic syndromeh (n = 945) 81 33.7 (25.2–42.1) 171 42.5 (36.1–48.8) 155 57.3 (47.4–67.3) <.001
Smoking historyi (n = 945) 160 51.5 (43.1–59.9) 175 45.2 (38.6–51.7) 102 40.0 (29.6–50.3) .20
Current smokerj (n = 945) 95 35.4 (27.2–43.6) 120 29.5 (23.8–35.3) 57 19.4 (12.9–25.8) .006
Sometimes drink (n = 945) 159 61.3 (53.5–69.1) 278 65.0 (58.7–71.3) 146 53.8 (43.9–63.8) .15
Heavy drinking (n = 945) 35 8.2 (4.7–11.6) 15 7.5 (3.4–11.6) 17 5.7 (2.3–9.1) .61
Insurance (n = 944) 49 19.2 (11.7–26.8) 119 30.5 (24.1–36.9) 152 61.8 (53.0–70.6) <.001
Continuous Variable, Mean Value
Age, y (95% Confidence Interval)
P Value18–34 35–54 ≥55
Waist circumference, cm (n = 945) 103.8 (100.8–106.8) 105.3 (103.5–107.1) 106.5 (104.7–108.3) .29
BMI, kg/m2 (n = 945) 31.2 (29.9–32.4) 31.3 (30.5–32.2) 30.2 (29.3–31.1) .19
SBP, mm Hg (n = 945) 116.0 (113.7–118.4) 116.8 (115.0–118.7) 125.2 (121.7–128.6) <.001
DBP, mm Hg (n = 945) 74.1 (72.4–75.8) 75.3 (74.0–76.7) 71.8 (69.8–73.9) .03
ALT, u/L (n = 945) 56.9 (49.5–64.3) 47.8 (45.2–50.5) 39.8 (36.5–43.0) <.001
AST, u/L (n = 945) 45.0 (39.5–50.6) 38.0 (36.0–40.0) 33.8 (30.6–37.0) .002
Triglycerides, mg/dL (n = 945) 182.5 (144.4–220.6) 230.9 (184.4–277.5) 195.9 (191.2–220.6) .01
HDL, mg/dL (n = 945) 41.7 (39.4–44.0) 42.7 (40.8–44.7) 42.1 (40.4–43.9) .71
LDL, mg/dL (n = 933) 92.2 (84.3–100.1) 108.6 (101.5–115.8) 102.2 (96.0–108.4) <.001
Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; CI, confidence interval; DBP, diastolic blood
pressure; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; LFTs, liver function tests; SBP, systolic blood pres-
sure.
a All statistics weighted. Percentages may not reflect the expected result due to sampling weights and design-based analyses.
b According to American Diabetes Association 2010 Diagnostic Guidelines (20).
c Defined as ALT >40 u/L and/or AST >37 u/L.
d Defined as <40 mg/dL.
e Defined as LDL >160 mg/dL.
f Defined as triglyceride levels >150 mg/dL.
g Defined as systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or taking antihypertensive medication.
h According to Adult Treatment Panel III (21).
i Defined as an affirmative response to, “Have you ever smoked more than 100 cigarettes in your entire life?”
j Defined as affirmative responses to 1) “Have you ever smoked more than 100 cigarettes in your entire life?” and 2) “Do you now smoke cigar-
ettes?”
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Table 3. Multiple Comparison Analysis of Variables, by Age Group, of Men in the Cameron County Hispanic Cohort (N = 945), 2004–2015
Categorical Variable Odds Ratioa
Diabetesb
18–34 1 [Reference]
35–54 1.8 (1.0 to 3.1)
≥55 3.0 (1.7 to 5.6)
Prediabetes or diabetes
18–34 1 [Reference]
35–54 1.5 (0.9 to 2.3)
≥55 4.4 (2.6 to 7.4)
Elevated liver function testsc
18–34 1 [Reference]
35–54 1.0 (0.6 to 1.6)
≥55 0.4 (0.3 to 0.8)
Hypertriglyceridemiad
18–34 1 [Reference]
35–54 2.2 (1.4 to 3.4)
≥55 1.5 (0.9 to 2.6)
Hypertensione
18–34 1 [Reference]
35–54 1.0 (0.6 to 1.8)
≥55 4.1 (2.2 to 7.7)
Metabolic syndromef
18–34 1 [Reference]
35–54 1.5 (0.9 to 2.3)
≥55 2.6 (4.5 to 4.6)
Health insurance
18–34 1 [Reference]
35–54 1.8 (1.1 to 3.2)
≥55 6.8 (3.8 to 12.3)
Current smokerg
18–34 1 [Reference]
a Survey-weighted odds ratio generated from logistic regression.
b According to American Diabetes Association 2010 Diagnostic Guidelines (20).
c Defined as alanine transaminase >40 u/L and/or aspartate aminotransferase >37 u/L.
d Defined as triglyceride levels >150 mg/dL.
e Defined as systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or taking antihypertensive medication.
f According to Adult Treatment Panel III (21).
g Defined as affirmative responses to 1) “Have you ever smoked more than 100 cigarettes in your entire life” and 2) “Do you now smoke cigar-
ettes?”
h Bonferroni adjusted P values for multiple pairwise comparisons.
i Nonsignificant after controlling for place of birth.
(continued on next page)
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(continued)
Table 3. Multiple Comparison Analysis of Variables, by Age Group, of Men in the Cameron County Hispanic Cohort (N = 945), 2004–2015
Categorical Variable Odds Ratioa
35–54 0.8 (0.5 to 1.2)
≥55 0.4 (0.3 to 0.8)
Continuous Variable Difference (95% Confidence Interval) P Valueh
Systolic blood pressure, mmHg
18–34 Reference
35–54 −0.8 (−4.5 to 2.9) .99
≥55 −9.1 (−14.2 to −4.0) <.001
Diastolic blood pressure, mmHg
18–34 Reference
35–54 −1.2 (−3.9 to 1.5) .82
≥55 2.3 (−1.0 to 5.5) .28
Triglycerides, mg/dL
18–34 Reference
35–54 −48.4 (−87.1 to −9.7) .008
≥55 −13.4 (−58.4 to 31.6) .99
Low-density lipoprotein cholesterol, mg/dL
18–34 Reference
35–54 −16.4 (−25.7 to −7.2) <.001
≥55 −10.0 (−20.1 to 0.1) .05
Alanine transaminase levels, u/L
18–34 Reference
35–54 9.1 (−0.6 to 18.9) .08
≥55 17.2 (7.4 to 27.0) <.001
Aspartate aminotransferase levels, u/L
18–34 Reference
35–54 7.1 (0.02 to 14.1)i .05i
≥55 11.2 (3.7 to 18.7) .001
a Survey-weighted odds ratio generated from logistic regression.
b According to American Diabetes Association 2010 Diagnostic Guidelines (20).
c Defined as alanine transaminase >40 u/L and/or aspartate aminotransferase >37 u/L.
d Defined as triglyceride levels >150 mg/dL.
e Defined as systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or taking antihypertensive medication.
f According to Adult Treatment Panel III (21).
g Defined as affirmative responses to 1) “Have you ever smoked more than 100 cigarettes in your entire life” and 2) “Do you now smoke cigar-
ettes?”
h Bonferroni adjusted P values for multiple pairwise comparisons.
i Nonsignificant after controlling for place of birth.
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